The incidence of antibodies to Epstein-Barr nucleair antigen type 2 (EBNA-2) was determined in sera from rheumatoid arthritis (RA) patients and control subjects, by protein immunoblotting. Sixty-eight percent of the RA patients and 48% of the controls possessed anti-EBNA-2 antibodies. The titer of a
A Search for Rheumatoid Arthritis-Associated Nuclear Antigen And Epstein-Barr Virus Specific Antigens or Genomes in Tissues and Cells from Patients with Rheumatoid Arthritis
โ Scribed by Margaret A. Alspaugh; Hiromu Shoji; Meihan Nonoyama
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 849 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
โฆ Synopsis
Pannus extracts and/or cells and tissues from rheumatoid arthritis (RA) patients and controls were tested for the presence of RA-associated nuclear antigen (RANA), anti-RANA, Epstein-Barr virus (EBV)-specific antigens, and EBV genomes. Using our present rather insensitive methods, RANA was rarely detected in RA pannus extracts or tissues, whereas anti-RANA was commonly found. EBV-specific antigens or genomes could not be detected in a limited number of tissues tested using our present methods. The data suggest that EBV may not be the primary event causing RA through direct infection and transformation of synovial tissues.
๐ SIMILAR VOLUMES